Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efinopegdutide - Hanmi Pharmaceutical

Next Previous
X
Search
Drug Profile

Efinopegdutide - Hanmi Pharmaceutical

Alternative Names: GLP-1/glucagon-agonist; Glucagon-like-peptides/glucagon; Glucagon/GLP-1-agonist; HM-12525A; JNJ 5111; JNJ-64565111; LAPS GLP/GCG; LAPS-GCG/GLP-1; LAPS-GLP-1/GCG; LAPS-GLP/Glucagon; LAPS-OXM; MK-6024; Oxyntomodulin immunoglobulin conjugate

Latest Information Update: 14 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hanmi Pharmaceutical
  • Developer Hanmi Pharmaceutical; Janssen Pharmaceuticals; Merck & Co
  • Class Antihyperglycaemics; Gastrointestinal hormones; Glucagon-like peptides; Obesity therapies; Recombinant fusion proteins
  • Mechanism of Action Glucagon receptor agonists; Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Liver cirrhosis; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis
  • Discontinued Obesity; Type 2 diabetes mellitus

Most Recent Events

  • 29 Jul 2024 Phase-II clinical trials in Non-alcoholic fatty liver disease in Puerto Rico (SC) (NCT06482112)
  • 29 Jul 2024 Phase-II clinical trials in Non-alcoholic fatty liver disease in USA (SC) (NCT06482112)
  • 12 Jul 2024 Phase-II clinical trials in Liver cirrhosis in Puerto Rico, USA (SC) (NCT06465186)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top